<DOC>
	<DOCNO>NCT01392339</DOCNO>
	<brief_summary>Obstructive sleep apnea multi-component disease . This study test hypotheses hypoxia per se modulates gene expression animal model sleep apnea result may translate alteration occur apneic patient . Thus , aim integrate basic clinical research shed light novel candidate gene involve sleep apnea .</brief_summary>
	<brief_title>Obstructive Sleep Apnea Genes Expression</brief_title>
	<detailed_description>Twenty-four male rat expose chronic intermittent hypoxia ( 5 % O2 ) normoxia 6 wks . Following chronic intermittent hypoxia , group 8 rat remove chronic intermittent hypoxia protocol allow normoxic condition period 2 wks . For clinical protocol , AHI measure overnight polysomnography use select individual sleep-related breathing disorder , control ( 30-60 year , Body Mass Index ( BMI ) &lt; 35kg/m2 ) . Moreover , investigator evaluate subjective sleep parameter ( sleep disorder questionnaire , Epworth Sleepiness Scale , sleep diary ) . After standard CPAP titration , men severe obstructive sleep apnea assign CPAP protocol future assessment influence 6 month obstructive sleep apnea treatment . A total 84 gene evaluate use Hypoxia Signaling Pathway PCR Array ( SA Biosciences , EUA ) .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Male subject age 30 60 year old Normal range laboratory test complete blood count ( CBC ) , glucose , total cholesterol , highdensity lipoprotein ( HDL ) , lowdensity lipoprotein ( LDL ) lowdensity lipoprotein ( LDL ) , triglycerides Body Mass Index ( BMI ) &lt; 35kg/m2 Presence clinical disease ( chronic obstructive pulmonary disease , asthma , interstitial lung disease , neuromuscular disease , heart failure , thyroid disease , rheumatologic psychiatric ) sleep disorder Smoking status Participants current historical treatment CPAP treatment OSA Presence anatomical obstructive upper airway , tonsil grade III IV septal deviation grade III ( severe ) may affect outcome CPAP Alcoholism Use sleepinducing medication</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>CPAP</keyword>
	<keyword>hypoxia</keyword>
	<keyword>sleep</keyword>
	<keyword>translational science</keyword>
	<keyword>gene expression</keyword>
</DOC>